Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Single Agent Pre-operative Metformin in Patients With Clinical Stage I - IIIA NSCLC Proceeding to Surgical Resection. 'Lung Metcore Study'

NCT03086733 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03086733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03086733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Single Agent Pre-operative Metformin in Patients With Clinical Stage I - IIIA NSCLC Proceeding to Surgical Resection. 'Lung Metcore Study'
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
December 5, 2016
Completion date
August 31, 2020
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, non small cell lung cancer